| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 2 securities · passive | ||||||
|
Oramed Pharmaceuticals Inc.
13G/A
ORMP · 68403P203
|
6.4% |
11/13/2026
Event 9/30/2026
|
||||
|
Pulsenmore Ltd.
13G
PLSM · M8S7C5117
|
5.0% |
10/8/2026
Event 3/31/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.